All Features

Use the tool below to view all available Global Neurology Academy Series

Popular

Managing NF1 PN with this First FDA-Approved Treatment Option
Managing NF1 PN with this First FDA-Approved Treatment Option
NeuroFrontiers
Managing NF1 PN with this First FDA-Approved Treatment Option
- Sandy Millman
- Pinki Prasad, MD
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
NeuroFrontiers
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
- Andrew Wilner, MD, FACP, FAAN
- Victoria Leavitt, PhD
Shedding Light on the Brain After COVID-19: Assessing the Spectrum of Neurological Risk
Shedding Light on the Brain After COVID-19: Assessing the Spectrum of Neurological Risk
NeuroFrontiers
Shedding Light on the Brain After COVID-19: Assessing the Spectrum of Neurological Risk
- Andrew Wilner, MD, FACP, FAAN
- Jennifer A. Frontera, MD